Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

42 results about "Serum specific ige" patented technology

The determination of allergen-specific IgE antibodies, combined with total serum IgE, is a very sensitive first-order test for allergic disease. And, unlike the measurement of total serum IgE, a negative result effectively rules out allergy induced by the allergen tested.

Diagnostic test for West Nile virus

The present invention provides a rapid and sensitive method for the detection of a West Nile virus (WNV), Japanese encephalitis virus (JEV), St. Louis encephalitis virus (SLEV) and Dengue virus (DENV) and antibodies directed against thereof involving contacting a biological specimen suspected of being infected with WNV, JE, SLE or DEN with a substantially purified and isolated WNV E glycoprotein or subfragment thereof having a native conformation wherein the E glycoprotein or subfragment thereof has a reactivity with antibodies against WNV and a cross-reactivity with antibodies against JEV, SLEV and DENV. The instant invention further provides a rapid, sensitive, and consistent method for the specific detection of WNV by employing diagnostic assays having the antigen NS5 which is specifically reactive with anti-WNV antibodies but not cross-reactive with antibodies against other flaviviruses such as JEV, SLEV, or DENV. The present invention also provides a rapid, sensitive, and consistent method for the specific detection of DENV by employing diagnostic assays having the antigen NS5 which is specifically reactive with anti-DENV antibodies but do not cross-react with antibodies against other flaviviruses such as JEV, SLEV, or WNV. Further, the DENV NS5 antigens are serospecific and do not cross react with antibodies to other DENV strains. Thus, the method of the present invention provides a manner by which to discriminate infections by each DENV strain. Further, diagnostic kits for carrying out the methods are provided. The methods and kits for carrying out the methods of the invention are rapid and require as little as 10 minutes to detect a result.
Owner:HEALTH RES INC

Diagnostic test for west nile virus

The present invention provides a rapid and sensitive method for the detection of a West Nile virus (WNV), Japanese encephalitis virus (JEV), St. Louis encephalitis virus (SLEV) and Dengue virus (DENV) and antibodies directed against thereof involving contacting a biological specimen suspected of being infected with WNV, JE, SLE or DEN with a substantially purified and isolated WNV E glycoprotein or subfragment thereof having a native conformation wherein the E glycoprotein or subfragment thereof has a reactivity with antibodies against WNV and a cross-reactivity with antibodies against JEV, SLEV and DENV. The instant invention further provides a rapid, sensitive, and consistent method for the specific detection of WNV by employing diagnostic assays having the antigen NS5 which is specifically reactive with anti-WNV antibodies but not cross-reactive with antibodies against other flaviviruses such as JEV, SLEV, or DENV. The present invention also provides a rapid, sensitive, and consistent method for the specific detection of DENV by employing diagnostic assays having the antigen NS5 which is specifically reactive with anti-DENV antibodies but do not cross-react with antibodies against other flaviviruses such as JEV, SLEV, or WNV. Further, the DENV NS5 antigens are serospecific and do not cross react with antibodies to other DENV strains. Thus, the method of the present invention provides a manner by which to discriminate infections by each DENV strain. Further, diagnostic kits for carrying out the methods are provided. The methods and kits for carrying out the methods of the invention are rapid and require as little as 10 minutes to detect a result. The invention also provides monoclonal antibodies against WNV NS5 and DENV NS5 antigen and their use in detecting WNV and DENV infections in a biological sample.
Owner:HEALTH RES INC

Serum specificity metabolite spectrum for patient with lung cancer, and building method thereof

ActiveCN103616450AEasy to handleStrong qualitative analysis abilityComponent separationGas phaseOriginal data
The invention discloses a serum specificity metabolite spectrum for a patient with a lung cancer and a building method thereof, and particularly discloses a method for carrying out liquid-phase/gas-phase chromatography mass spectrometry metabonomics analysis based on the patient suffering from the lung cancer. The method comprises the following steps: collecting fasting blood samples of a healthy and normal detected person and the patient suffering from the lung cancer 7 days before and after an operation, separating by a chromatogram column after processing; extracting and aligning original data of an instrument after adopting mass spectrometry analysis; building a mathematical model to analyze the metabolites spectrum by adopting multivariable data statistical software; comparing with the difference between an average person with the metabolites spectrum of the patient with the lung cancer, so as to determine the specificity metabolite spectrum. By adopting the method disclosed by the invention, the mutation status of the metabolite of the patient with the lung cancer can be generally and comprehensively reflected, and the serum specificity metabolite spectrum can be applied to early diagnosis of the lung cancer or a beneficial technical support is supplied for prognosis.
Owner:HUZHOU CENT HOSPITAL

Infectious genomic DNA clone and serological profile of torque teno sus virus 1 and 2

The present invention also provides infectious DNA clones, biologically functional plasmid or viral vector containing the infectious nucleic acid genome molecule of Torque teno sus virus (TTsuV). The present invention also provides methods for diagnosing TTsuV infection via immunological methods, e.g., enzyme-linked immunoabsorbent assay (ELISA) and Western blot using PTTV specific antigens for detecting serum PTTV specific antibodies which indicate infections TTsuV1, TTsuV2, and individual TTsuV1 genotypes.
Owner:VIRGINIA TECH INTPROP INC

Application of QX type IBV cellular adapted strain MJ to preparation of totivirus antigen ELISA inspection kit and kit

The invention provides application of a QX type IBV cellular adapted strain MJ to preparation of a totivirus antigen ELISA inspection kit and the kit, and belongs to the technical field of virus antibody inspection. According to the application of the QX type IBV cellular adapted strain MJ to the preparation of the totivirus antigen ELISA inspection kit, the preservation number of the QX type IBVcellular adapted strain MJ is CGMCC No. 14681, the cellular adapted strain MJ does not contain other viral antigens and is only in specific binding with an IBV positive serum, and cross reaction between the cellular adapted strain MJ and other virus positive serums is avoided, effective proliferation is conducted on a Vero cell, and the cellular adapted strain MJ is applied to effectively solve the problems that purification of IBV totivirus is difficult and non-specificity is high. The invention also provides the totivirus antigen indirect ELISA inspection reagent box constructed based on thecellular adaptive strain MJ. According to the totivirus antigen indirect ELISA inspection kit, detection sensitivity is high, specificity is strong, QX type IBV early infection can be inspected, andearly antibody level of chicken flock immune from attenuated vaccine can also be inspected.
Owner:JIANGSU INST OF POULTRY SCI

A serum-specific biomarker for diagnosing primary liver cancer and its screening method and application

A serum-specific biomarker for the diagnosis of primary liver cancer and its screening method and application, using the Boyden chamber to separate the protrusion and cell body of liver cancer metastatic cells, starting from the subcellular structure, using the improved Boyden chamber method to separate liver cancer metastatic cells For cell bodies and protrusions, the separation results were verified by Western-blot, RNA staining, immunofluorescence and other techniques. Study the differential expression in HCCLM3 liver cancer cell body and protrusion, and screen out microRNAs related to the invasion and metastasis of HCC. Clinical experiments have proved that the change of individual serum hsa-let-7c-3p has a higher diagnostic value for HCC. Sensitivity and specificity. The present invention will provide a new diagnostic method for clinical diagnosis of primary liver cancer, and has certain potential clinical value in assisting the treatment of HCC and monitoring the course of disease, through the ROC curve of let-7c-3p, and let-7c-3p The ROC curves of combined use with CEA, let-7c-3p with AFP, and let-7c-3p with AFP and CEA have improved sensitivity and specificity, and the diagnostic value has been significantly improved.
Owner:WENZHOU MEDICAL UNIV

Serum specific biomarker used for diagnosing primary liver cancer and screening method and application thereof

The invention relates to a serum specific biomarker used for diagnosing primary liver cancer and a screening method and an application thereof. According to the invention, a Boyden chamber is used forseparating extension and soma of liver cancer transfer cells, from a subcellular structure, an improved Boyden chamber method is used for separating extension and soma of liver cancer transfer cells,and the separating results can be verified by using the technologies such as Western-blot, RNA dyeing and immunofluorescence. The differential expression condition in HCCLM3 liver cancer cell extension and soma is researched, minimal RNA-related to a HCC infiltration transferring process is screened, and clinical experiment proves that change of individual serum has-let-7c-3p has high sensitivityand specificity on HCC diagnosis. The serum specific biomarker provides a novel diagnosis means for clinical diagnosis of the primary liver cancer, and has certain latent clinical value on HCC treatment and pathogenesis monitoring, through a ROC curve of let-7c-3p as well as the ROC curve of let-7c-3p and CEA combination, let-7c-3p and AFP combination, and let-7c-3p and AFP and CEA combination, sensitivity and specificity are increased, and diagnosis value can be obviously increased.
Owner:WENZHOU MEDICAL UNIV

A kind of test kit and application thereof for detecting the serum-specific miRNA of getting angry

The present invention relates to the application of miR-122-5p, miR-483-5p and miR-3197 in combination as molecular markers for getting angry in traditional Chinese medicine; it involves the combined use of miR-122-5p, miR-483-5p, miR-3197 and U6 Application in the preparation of traditional Chinese medicine miRNA detection kits; the present invention uses serum hsa-miR-122-5p, hsa-miR-483-5p and hsa-miR-3197 as diagnostic markers, verified by large samples, in practice In people with heat and fire, individual serum hsa-miR-122-5p, hsa-miR-483-5p or hsa-miR-3197 all have significantly low expression, and the kit provided by the invention is used to detect the constitution of excessive heat and fire , through simultaneous relative quantification of serum hsa‑miR‑122‑5p, hsa‑miR‑483‑5p and hsa‑miR‑3197 to identify excess heat and upper body fire constitution, the diagnostic sensitivity is 90.9%, and the specificity is 72.7% , has high accuracy and is higher than the diagnostic properties of a single miRNA. It can replace the traditional TCM diagnostic methods of looking, smelling, asking, and feeling, and combines the diagnosis of TCM syndromes with modern molecular biology to achieve standardization of diagnosis.
Owner:ZHEJIANG CHINESE MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products